Detection of residual prostate cancer after external radiotherapy. Role of prostate specific antigen and transrectal ultrasonography

Cancer

Volumn 75, Issue 8, 1995, Pages 2153-2158

  Babaian, R Joseph ^a   Kojima, Munekado ^a   Saitoh, Masahito ^a   Ayala, Alberto G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

biopsy; prostate cancer; prostate specific antigen; radiation therapy; transrectal ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BIOPSY; HUMAN; MALE; MIDDLE AGE; NEOPLASM, RESIDUAL; PALPATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0028946873     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950415)75:8<2153::AID-CNCR2820750819>3.0.CO;2-G     Document Type: Article

References (20)

1. Radiotherapy for localized prostate cancer
2. Potential for radiotherapy along in prostatic cancer
3. Tumor control in definitive irradiation of localized carcinoma of the prostate
4. Stage C adenocarcinoma of the prostate: an analysis of 551 patients treated with external beam radiation
5. The role of radiation therapy in stages A2 and B adenocarcinoma of the prostate
6. Radiotherapy for prostatic carcinoma: post‐irradiation prostatic biopsy and recurrence patterns with long‐term follow up
7. The significance of needle biopsy after irradiation for stage C adenocarcinoma of the prostate
8. Radiation injury of the normal and neoplastic prostate
9. Sonographic monitoring of prostate cancer after definitive radiotherapy
10. Ultrasonic volume monitoring in patient with prostate cancer treated by external beam radiation therapy
11. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III: radiation treated patients
12. Prostate‐specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy
13. 125 seed implantation for prostate cancer
14. Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen
15. Detection of residual cancer after radiotherapy by sonographically guided needle biopsy
16. Clinical relevance of trans‐rectal ultrasound, biopsy, and serum prostate‐specific antigen following external beam radiotherapy for carcinoma of the prostate
17. Latent residual rumor following external radiotherapy for prostate adenocarcinoma
18. External beam radiotherapy for adenocarcinoma of the prostate: a clinical follow‐up
19. The prognostic significance of post‐irradiation biopsy results in patients with prostatic cancer
20. 125iodine implant or external beam radiation therapy